News
Publications
Multimedia
Conferences
Webcasts
Resources
Subscribe

Spotlight -

Drug Development|

Quality Systems

Greg Swan

Greg Swan is business development manager for Cell & Gene Therapy at Avantor.

Articles by Greg Swan

Sveta/Stock.adobe.com – Advances in technologies are being used to enhance the manufacturing of viral vectors for gene therapies at each step of the manufacturing process.

Addressing Developmental Challenges of Gene Therapy Viral Vectors

ByGer Brophy,Arvind Srivastava,Greg Swan

October 15th 2022

Significant improvements have been developed to tackle the challenges in viral vector manufacturing at each stage.

Latest Updated Articles

Addressing Developmental Challenges of Gene Therapy Viral Vectors
October 15th 2022

Trending on Pharmaceutical Technology

FDA Guidance for Accelerating Gene Therapies for Rare Diseases

Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance

Implications of Pediatric Inhaled Insulin Approval

Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs

Generic GLP-1s Enter Canadian Market